Tracon Pharmaceuticals, Inc. (26)

Browse by Contract Category

Contracts

Loan and Security Agreement by and among the Company, each other party thereto as a borrower from time to time, the lenders from time to time party thereto and Runway Growth... (Filed With SEC on September 6, 2022)
TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 28, 2022 (Filed With SEC on March 15, 2022)
Collaborative Development and Commercialization Agreement by and among the Registrant, Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd.... (Filed With SEC on November 3, 2021)
Amendment One to License and Option Agreement between the Registrant and Janssen Pharmaceutica N.V. dated January 15, 2019 (Filed With SEC on March 1, 2019)
Form of Warrant to Purchase Common Stock (Filed With SEC on September 6, 2022)
Securities Purchase Agreement, between the Company and the Purchaser, dated June 21, 2022 (Filed With SEC on June 21, 2022)
Form of Amended and Restated Pre-Funded Warrant 2 (Filed With SEC on June 21, 2022)
Form of Amended and Restated Pre-Funded Warrant 1 (Filed With SEC on June 21, 2022)
Form of Pre-Funded Warrant (Filed With SEC on June 21, 2022)
Amended and Restated Underwriting Agreement, dated July 21, 2021, by and between TRACON Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on July 22, 2021)
TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 29, 2021 (Filed With SEC on February 25, 2021)
Amendment #2 to Cooperative Research and Development Agreement by and between the Registrant and the U.S. Department of Health and Human Services, as represented by National... (Filed With SEC on February 25, 2021)
Employment Agreement by and between the Registrant and Mark Wiggins, dated January 27, 2021 (Filed With SEC on February 25, 2021)
TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 29, 2021 (Filed With SEC on February 25, 2021)
Deferral agreement to Amended and Restated Loan and Security Agreement between the Registrant and Silicon Valley Bank dated April 10, 2020 (Filed With SEC on April 15, 2020)
Collaboration and Clinical Trial Agreement by and among the Registrant, 3D Medicines (Beijing) Co., LTD. and Jiangsu Alphamab Biopharmaceuticals Co., LTD. dated December 20, 2019 (Filed With SEC on February 28, 2020)
Severance Agreement by and between the Registrant and Scott Brown, dated December 4, 2019 (Filed With SEC on February 28, 2020)
Employment Agreement by and between the Registrant and Scott Brown, dated January 28, 2020 (Filed With SEC on February 28, 2020)
TRACON Pharmaceuticals, Inc. Bonus Plan, as amended January 28, 2020 (Filed With SEC on February 28, 2020)
TRACON Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended January 31, 2020 (Filed With SEC on February 28, 2020)
Description of Capital Stock (Filed With SEC on February 28, 2020)
Amendment No. 1 to Capital on DemandTM Sales Agreement, dated as of February 28, 2019, by and between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on November 5, 2019)
Registration Rights Agreement, dated October 18, 2019, between TRACON Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
Employment Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)
Severance Agreement by and between the Registrant and Mark Wiggins, dated May 29, 2018 (Filed With SEC on March 1, 2019)
Amended and Restated Employment Agreement by and between the Registrant and Charles P. Theuer, M.D., Ph.D., dated February 5, 2019 (Filed With SEC on March 1, 2019)